0001564590-19-021788.txt : 20190605 0001564590-19-021788.hdr.sgml : 20190605 20190605164549 ACCESSION NUMBER: 0001564590-19-021788 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190531 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20190605 DATE AS OF CHANGE: 20190605 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Achaogen, Inc. CENTRAL INDEX KEY: 0001301501 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680533693 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36323 FILM NUMBER: 19880298 BUSINESS ADDRESS: STREET 1: 1 TOWER PLACE STREET 2: SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-800-3636 MAIL ADDRESS: STREET 1: 1 TOWER PLACE STREET 2: SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Achaogen Inc DATE OF NAME CHANGE: 20040825 8-K 1 akao-8k_20190531.htm 8-K akao-8k_20190531.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 31, 2019

 

ACHAOGEN, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware

 

001-36323

 

68-0533693

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification Number)

 

1 Tower Place, Suite 400

South San Francisco, CA 94080

(Address of principal executive offices, including Zip Code)

Registrant’s telephone number, including area code: (650) 800-3636

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock

AKAO

None

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


Item 7.01 Regulation FD Disclosure

As previously disclosed, on April 15, 2019, Achaogen, Inc. (the ‘Company’) filed a voluntary petition for bankruptcy protection under Chapter 11 of Title 11 of the United States Bankruptcy Code. The filing was made in the United States Bankruptcy Court for the District of Delaware (the ‘Court’) (Case No. 19-10844).

On May 31, 2019, the Company filed its monthly operating report (the ‘Monthly Operating Report’) with the Court for the reporting period of April 15 to April 30, 2019, a copy of which is attached hereto as Exhibit 99.1.

Cautionary Note Regarding the Monthly Operating Report

The Company cautions investors and potential investors not to place undue reliance upon the information contained in the Monthly Operating Report, which was not prepared for the purpose of providing the basis for an investment decision relating to any of the securities of the Company. The Monthly Operating Report is limited in scope and has been prepared solely for the purpose of complying with requirements of the Court. The Monthly Operating Report was not reviewed by independent accountants, is in a format prescribed by applicable bankruptcy laws, and is subject to future adjustment. The financial information in the Monthly Operating Report is not prepared in accordance with accounting principles generally accepted in the United States (‘GAAP’) and, therefore, may exclude items required by GAAP, such as certain reclassifications, eliminations, accruals, valuations and disclosures. The Monthly Operating Report also relates to periods which are different from the historical periods required in the Company’s reports pursuant to the Securities Exchange Act of 1934, as amended (the ‘Exchange Act’).

Limitation on Incorporation by Reference

In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01 is being furnished for informational purposes only and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as otherwise expressly stated in such filing. The filing of this current report (including Exhibit 99.1 attached hereto) will not be deemed an admission as to the materiality of any information required to be disclosed solely by Regulation FD.

Cautionary Statements Regarding Trading in the Company’s Securities

The Company’s securityholders are cautioned that trading in the Company’s securities is highly speculative and poses substantial risks during the pendency of the Chapter 11 case. Trading prices for the Company’s securities may bear little or no relationship to the actual recovery, if any, by holders thereof in the Company’s Chapter 11 case. Accordingly, the Company urges extreme caution with respect to existing and future investments in its securities.

 

 

 

 

 

 

 

 

 

 

 


Cautionary Note Regarding Forward-Looking Statements

This Current Report on Form 8-K and Exhibit 99.1 contains certain statements that are, or may be deemed to be, “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act. Statements including words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “expect,” “anticipate,” “believe,” “seek,” “target” or similar expressions are forward-looking statements. These statements reflect the Company’s current views, expectations and beliefs concerning future events. In addition, any statements related to the Company’s plans to sell all of its assets pursuant to Chapter 11 of the U.S. Bankruptcy Code; the Company’s intention to continue operations during the Chapter 11 case; the Company’s belief that the sale process will be in the best interest of the Company and its stakeholders; the continued uninterrupted access to the Company’s product during the Chapter 11 proceedings; and other statements regarding the Company’s strategy and future operations, performance and prospects are forward-looking statements. Such plans, expectations and statements are as to future events and are not to be viewed as facts, and reflect various assumptions of management of the Company and are subject to significant business, financial, economic, operating, competitive, litigation and other risks and uncertainties and contingencies (many of which are difficult to predict and beyond the control of the Company) that could cause actual results to differ materially from the statements included herein, including, without limitation: the potential adverse impact of the Chapter 11 filings on the Company’s liquidity and results of operations; changes in the Company’s ability to meet its financial obligations during the Chapter 11 process and to maintain contracts that are critical to its operations; the outcome and timing of the Chapter 11 process and the proposed auction and asset sale; the effect of the Chapter 11 filings and proposed asset sale on the Company’s relationships with vendors, regulatory authorities, employees and other third parties; possible proceedings that may be brought by third parties in connection with the Chapter 11 process or the proposed asset sale; uncertainty regarding obtaining bankruptcy court approval of a sale of the Company’s assets or other conditions to the proposed asset sale; and the timing or amount of any distributions, if any, to the Company’s stakeholders. The inclusion of forward-looking statements should not be regarded as a representation by Achaogen that any of its plans will be achieved. Investors should note that many factors, including those more fully described in the Company’s filings with the Commission (including, but not limited to, its Annual Report on Form 10-K for the year ended December 31, 2018 filed on April 1, 2019 and other filings with the Commission), could affect the Company’s future financial results and could cause actual results to differ materially from those expressed in forward-looking statements, such as those contained in this Current Report on Form 8-K and Exhibit 99.1. The forward-looking statements in this Current Report on Form 8-K and Exhibit 99.1 are qualified by risk factors identified by the Company. These risk factors, individually or in the aggregate, could cause our actual results to differ materially from expected and historical results. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company assumes no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

Additional Information Regarding the Chapter 11 Case

Additional information about the Chapter 11 case and structured sale process is available through the Company’s claims agent Kurtzman Carson Consultants LLC at www.kccllc.net/achaogen. Information contained on, or that can be accessed through, such web site or the Court’s web site is not part of this Current Report.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits.

 

 

 

Exhibit Number

 

Description

99.1

 

Monthly Operating Report, dated May 31, 2019

 

 

 

 



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

ACHAOGEN, INC.

 

 

 

 

Date:  June 5, 2019

 

By:

/s/ Gary Loeb

 

 

 

Gary Loeb

 

 

 

General Counsel

 

EX-99.1 2 akao-ex991_7.htm EX-99.1 akao-ex991_7.htm

Exhibit 99.1

UNITED STATES BANKRUPTCY COURT

FOR THE DISTRICT OF DELAWARE

 

 

 

 

Achaogen, Inc.

  

Case No. 19-10844 (BLS)

Debtor

  

Reporting Period: April 15, 2019 - April 30, 2019

MONTHLY OPERATING REPORT

 

Submit copy of report to any official committee appointed in the case.

 

 

REQUIRED DOCUMENTS

 

Form No.

 

Document Attached

 

Explanation Attached

 

Affidavit/Supplement Attached

Schedule of Cash Receipts and Disbursements

 

MOR-1

 

X

 

 

 

 

     Bank Reconciliation (or copies of debtor's bank reconciliations)

 

MOR-1a

 

X

 

 

 

Certification Attached

     Schedule of Professional Fees Paid

 

MOR-1b

 

X

 

 

 

 

     Copies of bank statements

 

 

 

 

 

 

 

Certification Attached

     Cash disbursements journals

 

 

 

 

 

 

 

Certification Attached

Statement of Operations

 

MOR-2

 

X

 

 

 

 

Balance Sheet

 

MOR-3

 

X

 

 

 

 

Status of Post-Petition Taxes

 

MOR-4

 

X

 

 

 

Certification Attached

    Copies of IRS Form 6123 or payment receipt

 

 

 

 

 

 

 

 

    Copies of tax returns filed during reporting period

 

 

 

 

 

 

 

Certification Attached

Summary of Unpaid Post-Petition Debts

 

MOR-4

 

X

 

 

 

 

    Listing of aged accounts payable

 

MOR-4

 

X

 

 

 

 

Accounts Receivable Reconciliation and Aging

 

MOR-5

 

X

 

 

 

 

Debtor Questionnaire

 

MOR-5

 

X

 

 

 

 

 

I declare under penalty of perjury (28 U.S.C. Section 1746) that this report and the attached documents are true and correct to the best of my knowledge and belief.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

/s/ Nicholas K. Campbell

 

 

 

 

 

5/31/2019

 

 

Signature of Authorized Individual*

 

 

 

 

 

Date

 

 

 

 

 

 

 

Nicholas K. Campbell

 

 

 

 

 

Chief Restructuring Officer

 

 

Printed Name of Authorized Individual

 

 

 

 

 

Title of Authorized Individual

 

*

Authorized individual must be an officer, director or shareholder if debtor is a corporation; a partner if debtor is a partnership; a manager or member if debtor is a limited liability company.

 

 

 


Exhibit 99.1

UNITED STATES BANKRUPTCY COURT

FOR THE DISTRICT OF DELAWARE

 

 

 

 

Achaogen, Inc.

  

Case No. 19-10844 (BLS)

Debtor

  

Reporting Period: April 15, 2019 - April 30, 2019

Certification Regarding Post-Petition Bank Account

Reconciliation, Cash Disbursements Journals, and

Compliance and Payment of Post-Petition Taxes

I, Nicholas K Campbell, Chief Restructuring Officer, of Achaogen, Inc. (the “Debtor”) hereby certify the following:

1. Attached to MOR-1a is a listing of the Debtor’s bank accounts, by account number, and closing balances. These accounts are reconciled monthly in accordance with the Debtor’s ordinary course accounting practices and are available to the United States Trustee upon request.

2. Cash disbursement journals are maintained in accordance with the Debtor’s ordinary course accounting practices and are available to the United States Trustee upon request.

3. To the best of my knowledge and belief, the Debtor is current on all post-petition taxes, and no post-petition tax amounts are past due.

4. Debtor was granted an extension to file 2018 tax returns.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

/s/ Nicholas K. Campbell

 

 

 

 

 

 

5/31/2019

 

 

Nicholas K Campbell

Chief Restructuring Officer

 

 

 

 

 

 

Date

 

 


Exhibit 99.1

UNITED STATES BANKRUPTCY COURT

FOR THE DISTRICT OF DELAWARE

 

 

 

 

Achaogen, Inc.

  

Case No. 19-10844 (BLS)

Debtor

  

Reporting Period: April 15, 2019 - April 30, 2019

Notes to Monthly Operating Report

Debtor in Possession Financial Statements

The financial statements and supplemental information presented in this Monthly Operating Report (“MOR”) have been prepared using the Debtor’s books and records solely to comply with the requirements of the monthly reporting requirements under the United States Bankruptcy Code and those of the United States Trustee.

The financial statements and supplemental information presented herein are unaudited, preliminary in nature, and may not comply with generally accepted accounting principles in the United States of America (“U.S. GAAP”) in all material respects. These preliminary unaudited financial statements and other information represent the Debtor’s good faith attempt to comply with the requirements of the United States Bankruptcy Code and those of the United States Trustee using the resources available. This information is limited in scope to the requirements of this report.

These preliminary unaudited financial statements have not been subject to procedures that would typically be applied to financial information presented in accordance with U.S. GAAP, and upon application of such procedures, the Debtor believes that the financial information could be subject to changes, which could be material. Certain totals may not sum due to rounding.

All related tax implications are not currently reflected in the preliminary unaudited financial statements herein. The financial impact of potential tax and other adjustments on the accompanying preliminary unaudited financial statements cannot be determined at this time.

There may be adjustments to the opening balance sheet as of April 15, 2019 that will impact these accompanying preliminary unaudited financial statements. ASC 805 permits a one-year measurement period in which the opening balance sheet can be adjusted if additional information becomes available.

Liabilities Subject to Compromise

As a result of the commencement of the Debtor’s chapter 11 case, the payment of certain prepetition indebtedness of the Debtor is subject to compromise or other treatment under a plan of reorganization.

Restructuring / Reorganization Items

ASC 852 requires expenses and income directly associated with the Debtor’s chapter 11 cases to be reported separately in the income statement as reorganization items. Reorganization items includes write off of discount, premium, debt issuance costs, and derivatives associated with long-term debt, expenses related to legal advisory and representation services, other professional consulting and advisory services, estimates of claims allowed related to legal matters and rejected executory contracts and changes in liabilities subject to compromise recognized as there are changes in amounts expected to be allowed as claims.

Litigation

The Debtor is subject to lawsuits and claims that arise out of its operations in the normal course of business.  

 


Exhibit 99.1

 

 

 

Achaogen, Inc.

  

Case No. 19-10844 (BLS)

Debtor

  

Reporting Period: April 15, 2019 - April 30, 2019

 

Prior to the petition date, the Debtor was the defendant to various legal proceedings, described in detail in the most recent publicly filed financial statements, which are stayed during the course of the chapter 11 bankruptcy proceedings.

There are uncertainties inherent in any litigation and appeal and the Debtor cannot predict the outcome. At this time the Debtor is unable to estimate possible losses or ranges of losses that may result from such legal proceedings described in detail in the most recent publicly filed financial statements, and it has not accrued any amounts in connection with such legal proceedings in the financial statements herein, other than attorney's fees accrued prior to the petition date.

Sales Transaction

The Debtor is seeking a sale of substantially all of its assets through section 363 of the Bankruptcy Code. This auction will commence on June 3, 2019 with a deadline to close the sale transaction by June 28, 2019.

Reservation of Rights

Given the complexity of the Debtors’ business, inadvertent errors, omissions or over inclusion of contracts or leases may have occurred. Accordingly, the Debtors hereby reserve all of their rights to dispute the validity, status, enforceability, or executory nature of any claim amount, representation or other statement in this Monthly Operating Report and reserve the right to amend or supplement this Monthly Operating Report, if necessary, but shall be under no obligation to do so.



Exhibit 99.1

 

 

 

Achaogen, Inc.

  

Case No. 19-10844 (BLS)

Debtor

  

Reporting Period: April 15, 2019 – April 30, 2019

 

MOR-1

Consolidated Schedule of Cash Receipts and Disbursement

For the Period: April 15, 2019 - April 30, 2019

(Unaudited)

 

$ USD '000's

April 15 - April 30, 2019

 

Beginning Cash Balance (GL)

$

1,436

 

Receipts

 

 

 

Product

 

18

 

BARDA - C-Scape

 

386

 

Sub-lease Income

 

-

 

Asset Sales Receipts

 

-

 

Other

 

62

 

Total Receipts

 

466

 

Operating Disbursements

 

 

 

Salary, Wages, and Benefits

 

(279

)

Technical Operations

 

-

 

Sales & Marketing

 

(88

)

Development

 

(141

)

Medical Affairs

 

-

 

C-Scape

 

(100

)

Research

 

5

 

G&A - Facilities

 

(2

)

G&A - IT

 

(116

)

G&A - Finance and Accounting

 

(21

)

G&A - Legal

 

-

 

G&A - Other

 

(67

)

Total Operating Disbursements

 

(811

)

Operating Cash Flow

 

(344

)

Bankruptcy / Reorganization Costs

 

 

 

Professional Fees & UST

 

(41

)

DIP Interest / Adequate Protection

 

-

 

Critical Vendor Payments

 

-

 

Utility Deposits

 

-

 

Total Bankruptcy / Reorganization Costs

 

(41

)

Total Disbursements

 

(852

)

Net Cash Flow

 

(385

)

DIP Draw

 

2,139

 

Ending Operating Cash Balance

 

3,190

 

Carve Out

 

41

 

Ending Cash Balance (GL)

$

3,230

 

 

 

 

 

 

 

 

 


Exhibit 99.1

Achaogen, Inc.

  

Case No. 19-10844 (BLS)

Debtor

  

Reporting Period: April 15, 2019 - April 30, 2019

 

 

 

MOR - 1a

Schedule of Bank Reconciliation

For the Period: April 15, 2019 - April 30, 2019

(Unaudited)

 

 

$ USD '000's

SVB Account #

GL Balance

 

 

Sweep Redemption

 

 

In Transit Deposit

 

 

Unrecord Disbursement

 

 

Other Recon items

 

 

Outstanding Checks/ACH

 

 

Bank Balance

 

SVB Operating Checking

4224

$

1,327

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

90

 

 

$

194

 

 

$

1,611

 

Cash Clearing

 

 

(1,780

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1,780

)

Restricted Cash - Gates Grant

 

 

169

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

169

 

Restricted Cash - Gates Equity

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Long Term Restricted Cash - Gates

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Subtotal

 

 

(284

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

90

 

 

 

194

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SVB - Carve-out

3218

 

41

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

41

 

SVB - Utilities

3203

 

50

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

50

 

SVB Cash Sweep Account

3256

 

2,221

 

 

 

-

 

 

 

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,221

 

Long Term Restricted Cash

6905

 

530

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

530

 

SVB AR Cash

5720

 

672

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0

 

 

 

 

 

 

 

672

 

Cash and cash equivalents

 

 

3,230

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

90

 

 

 

194

 

 

 

3,514

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Securities

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

ST investment - SAM

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Cash Equivalent - FV adjustment

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

ST investment - FV adjustment

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Cash and cash equivalents and ST Invest

 

$

3,230

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

90

 

 

$

194

 

 

$

3,514

 

 

 

 

 

 

 

 

 


Exhibit 99.1

Achaogen, Inc.

  

Case No. 19-10844 (BLS)

Debtor

  

Reporting Period: April 15, 2019 - April 30, 2019

 

 

 

 

MOR-1b

Schedule of Professional Fees and Expenses Paid

For the Period: April 15, 2019 - April 30, 2019

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

Month Ended 4/30/19

 

Cumulative Since Filing

Payee

 

Category

 

Payor

 

Date

 

Period Covered

 

Fees

 

Expenses

 

Fees

 

Expenses

None

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Exhibit 99.1

Achaogen, Inc.

  

Case No. 19-10844 (BLS)

Debtor

  

Reporting Period: April 15, 2019 - April 30, 2019

 

 

 

 

MOR-2

Statement of Operations

For the Period: April 15, 2019 - April 30, 2019

(Unaudited)

 

$ USD '000's

April 15 - April 30, 2019

 

Revenues

 

 

 

Product revenue, net

$

51

 

Contract revenue

 

41

 

Total Revenues

 

92

 

Operating Expenses

 

 

 

Cost of sales

 

1

 

Research and development

 

779

 

Selling, general and administrative

 

499

 

Total Operating Expenses

 

1,279

 

Loss from operations

 

(1,186

)

 

 

 

 

Restructuring / Reorganization Costs

 

-

 

Interest and loan related expenses

 

(1,325

)

Change in warrant and derivative liabilities (1)

 

10,912

 

Other income, net

 

10

 

 

 

 

 

Net income / (loss)

$

8,411

 

 

 

 

 

 

 

 

 

 

Notes:

 

(1) Change in estimated fair value of the warrant liability, mainly due to the change in stock price.

 

 

 

 

 

 


Exhibit 99.1

Achaogen, Inc.

  

Case No. 19-10844 (BLS)

Debtor

  

Reporting Period: April 15, 2019 - April 30, 2019

 

 

 

MOR-3

Balance Sheet

(Unaudited)

 

$ USD '000's

As of April 15, 2019

 

 

As of April 30, 2019

 

Assets

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash and cash equivalents (1)

$

729

 

 

$

2,531

 

Restricted cash

 

169

 

 

 

169

 

Short-term investments

 

-

 

 

 

-

 

Trade and contract receivables, net

 

833

 

 

 

641

 

Inventory

 

513

 

 

 

512

 

Assets held for sale

 

481

 

 

 

481

 

Prepaids and other current assets

 

3,726

 

 

 

3,576

 

Total current assets

 

6,451

 

 

 

7,910

 

Non-current assets:

 

 

 

 

 

 

 

Property and equipment, net

 

2,336

 

 

 

2,298

 

Operating lease right-of-use assets

 

8,371

 

 

 

8,387

 

Non-current restricted cash

 

530

 

 

 

530

 

Non-current inventory

 

11,274

 

 

 

11,274

 

Other long-term assets

 

9,615

 

 

 

9,554

 

Total assets

$

38,577

 

 

$

39,953

 

Liabilities and stockholders’ equity (deficit)

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Accounts payable

 

13,002

 

 

 

13,625

 

Accrued liabilities

 

4,780

 

 

 

5,806

 

DIP loan

 

-

 

 

 

2,139

 

Deferred revenue

 

-

 

 

 

-

 

Warrant liability

 

13,376

 

 

 

2,463

 

Operating lease liabilities

 

18,497

 

 

 

18,505

 

Derivative liability

 

978

 

 

 

978

 

Total liabilities not subject to compromise

 

50,633

 

 

 

43,516

 

Total liabilities subject to compromise (2)

 

15,000

 

 

 

15,000

 

Total liabilities

 

65,633

 

 

 

58,516

 

Stockholders' equity (deficit)

 

 

 

 

 

 

 

Common stock

 

46

 

 

 

46

 

Preferred stock

 

-

 

 

 

-

 

Additional paid-in-capital

 

569,249

 

 

 

569,331

 

Accumulated deficit

 

(596,351

)

 

 

(587,940

)

Accumulated other comprehensive loss

 

-

 

 

 

-

 

Total stockholders' equity (deficit)

 

(27,056

)

 

 

(18,563

)

Total liabilities and stockholders’ equity (deficit)

$

38,577

 

 

$

39,953

 

 

 

 

 

 

 

 

 

Notes:

 

 

 

 

 

 

 

(1) Includes utility and professional fee carve out account balances.

 

(2) Currently consists of prepetition term loan outstanding balance.

 

 


Exhibit 99.1

Achaogen, Inc.

  

Case No. 19-10844 (BLS)

Debtor

  

Reporting Period: April 15, 2019 - April 30, 2019

 

 

 

MOR-4

Status Post-Petition Taxes

For the Period: April 15, 2019 - April 30, 2019

(Unaudited)

 

The beginning tax liability should be the ending liability from the prior month or, if this is the first report, the amount should be zero.

Attach photocopies of any tax returns filed during the reporting period.

 

$ USD '000's

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Beg. Tax Liability

 

 

Amount Withheld or Accrued

 

 

Amount Paid

 

 

Date Paid

 

Ending Tax Liability

 

Federal

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Withholding

$

-

 

 

$

38

 

 

$

38

 

 

4/30/2019

 

$

-

 

FICA-Employee

 

-

 

 

 

11

 

 

 

11

 

 

4/30/2019

 

 

-

 

FICA-Employer

 

-

 

 

 

11

 

 

 

11

 

 

4/30/2019

 

 

-

 

Unemployment

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

-

 

Income

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

-

 

Other: Medicare sur tax

 

-

 

 

 

1

 

 

 

1

 

 

4/30/2019

 

 

-

 

   Total Federal

 

-

 

 

 

61

 

 

 

61

 

 

 

 

 

-

 

State and Local

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Withholding

 

-

 

 

 

18

 

 

 

18

 

 

4/30/2019

 

 

-

 

Sales

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

-

 

Excise

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

-

 

Unemployment

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

-

 

Real Property

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

-

 

Personal Property

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

-

 

Other

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

-

 

   Total State and Local

 

-

 

 

 

18

 

 

 

18

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Taxes

$

-

 

 

$

79

 

 

$

79

 

 

 

 

$

-

 

 

 

 

 

 


Exhibit 99.1

Achaogen, Inc.

  

Case No. 19-10844 (BLS)

Debtor

  

Reporting Period: April 15, 2019 - April 30, 2019

 

 

 

MOR-4

Summary of Unpaid Post-Petition Accounts Payables

As of April 30, 2019

(Unaudited)

 

$ USD '000's

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number of Days Past Due

 

Post-Petition Accounts Payable Aging

Current (2)

 

0-30

 

31-60

 

61-90

 

Over 90

 

Total

 

Post-Petition Accounts Payable (1)

$

1,097

 

$

-

 

$

-

 

$

-

 

$

-

 

$

1,097

 

Total

$

1,097

 

$

-

 

$

-

 

$

-

 

$

-

 

$

1,097

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Notes:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) The about represents post-petition trade payables recorded in Debtor's subledger.

 

(2) Includes supplier invoices received early for future services (i.e. subscription services).

 

 

 

 

 

 


Exhibit 99.1

Achaogen, Inc.

  

Case No. 19-10844 (BLS)

Debtor

  

Reporting Period: April 15, 2019 - April 30, 2019

 

 

 

MOR-5

Accounts Receivable Aging

As of April 30, 2019

(Unaudited)

 

$ USD '000s

 

 

 

 

 

Accounts Receivable Reconciliation

 

 

Amount

 

Total Accounts Receivable at the beginning of the reporting period

 

 

$

833

 

+ Amounts billed during the period

 

 

 

212

 

- Amounts collected during the period

 

 

 

(404

)

Total Accounts Receivable at the end of the reporting period

 

 

$

641

 

 

 

 

 

 

 

Accounts Receivable Aging

 

 

Amount

 

0 - 30 days old

 

 

$

525

 

31 - 60 days old

 

 

 

130

 

61 - 90 days old

 

 

 

127

 

91+ days old

 

 

 

77

 

Total Accounts Receivable

 

 

 

858

 

Amount considered uncollectible (Bad Debt)

 

 

 

(217

)

Accounts Receivable (Net)

 

 

$

641

 

 


Exhibit 99.1

Achaogen, Inc.

  

Case No. 19-10844 (BLS)

Debtor

  

Reporting Period: April 15, 2019 - April 30, 2019

 

Debtor Questionnaire

 

 

 

 

Must be completed each month

Yes

No

1.  Have any assets been sold or transferred outside the normal course of business this reporting period?

 

X

     If yes, provide an explanation below.

 

 

 

 

 

2.  Have any funds been disbursed from any account other than a debtor in possession account this

 

X

     reporting period?  If yes, provide an explanation below.

 

 

 

 

 

3.  Have all post-petition tax returns been timely filed?  If no, provide an explanation below.

X

 

 

 

 

4.  Are workers compensation, general liability and other necessary insurance coverages in effect?

X

 

     If no, provide an explanation below.

 

 

 

 

 

5.  Has any bank account been opened during the reporting period?  If yes, provide

X

 

     documentation identifying the opened account(s).  If an investment account has been opened

 

 

     provide the required documentation pursuant to the Delaware Local Rule 4001-3.